Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.
By A. Scheen, N. Finer, P. Hollander, M. Jensen, Luc F Van Gaal. The Lancet, 2006
738 citations recorded by the source corpus.
Subfields: Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/cc981a9c63635e6a1322f160d6de92f529a86746
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
Citations in the corpus
- Targeting the endocannabinoid system: to enhance or reduce? (2008, background): “The first such compound, rimonabant, successfully completed four Phase III trial”